Microbial Derived Isoprene and Methods for Making the Same
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 5 of these applications claim priority to application 61/202,474, filed Mar 3, 2009. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,492,605 | Microbial Derived Isoprene and Methods for Making the Same In force · High confidence | Amyris, Inc. | In force | High confidence | ||
| US 10,125,376 | Microbial Derived Isoprene and Methods for Making the Same Grace period ended Nov 13, 2026 · lapse expected · Low confidence | Amyris, Inc. | Grace period ended Nov 13, 2026 lapse expected | Low confidence | ||
| US 9,233,894 | Microbial derived isoprene and methods for making the same In force · High confidence | Amyris, Inc. | In force | High confidence | ||
| US 9,885,061 | Microbial derived isoprene and methods for making the same In force · High confidence | Amyris, Inc. | In force | High confidence | ||
| US 8,324,442 | Microbial Derived Isoprene and Methods for Making the Same In force · High confidence | Amyris, Inc. | In force | High confidence |
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.